Aptose Biosciences Inc (NAS:APTO)
$ 0.39093 0.010425 (2.74%) Market Cap: 7.57 Mil Enterprise Value: 207,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 30/100

Q4 2022 Aptose Biosciences Inc Earnings Call Transcript

Mar 23, 2023 / 09:00PM GMT
Release Date Price: $8.55 (-2.55%)
Operator

Hello, and thank you for standing by, and welcome to Aptose Biosciences reports for the fourth quarter and year-end 2022 Conference Call. (Operator Instructions) I would now like to hand the conference over to Susan Pietropaolo, you may begin.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Towanda. Good afternoon, and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the year-end and fourth quarter ended December 31, 2022. Earlier today, Aptose issued a press release relating to these financial results. The news release, as well as related SEC filings, are accessible on Aptose's website.

Joining me on today's call are Dr. William D. Rice, Chairman, President and CEO; Dr. Rafael Bejar, Senior Vice President and Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President and Chief Financial Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot